IRIS Accounts Production v24.3.2.46 13250165 director 1.4.23 30.3.24 30.3.24 false true false false true false Ordinary Share 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh132501652023-03-31132501652024-03-30132501652023-04-012024-03-30132501652022-03-31132501652022-04-012023-03-31132501652023-03-3113250165ns15:EnglandWales2023-04-012024-03-3013250165ns14:PoundSterling2023-04-012024-03-3013250165ns10:Director12023-04-012024-03-3013250165ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3013250165ns10:SmallEntities2023-04-012024-03-3013250165ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3013250165ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3013250165ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3013250165ns10:FullAccounts2023-04-012024-03-3013250165ns10:OrdinaryShareClass12023-04-012024-03-3013250165ns10:RegisteredOffice2023-04-012024-03-3013250165ns5:CurrentFinancialInstruments2024-03-3013250165ns5:CurrentFinancialInstruments2023-03-3113250165ns5:ShareCapital2024-03-3013250165ns5:ShareCapital2023-03-3113250165ns5:RetainedEarningsAccumulatedLosses2024-03-3013250165ns5:RetainedEarningsAccumulatedLosses2023-03-3113250165ns5:PlantMachinery2023-03-3113250165ns5:FurnitureFittings2023-03-3113250165ns5:PlantMachinery2023-04-012024-03-3013250165ns5:FurnitureFittings2023-04-012024-03-3013250165ns5:PlantMachinery2024-03-3013250165ns5:FurnitureFittings2024-03-3013250165ns5:PlantMachinery2023-03-3113250165ns5:FurnitureFittings2023-03-3113250165ns10:OrdinaryShareClass12024-03-30
REGISTERED NUMBER: 13250165 (England and Wales)










Carlisle Hair Loss Clinic Ltd

Unaudited Financial Statements

for the Period 1 April 2023 to 30 March 2024






Carlisle Hair Loss Clinic Ltd (Registered number: 13250165)






Contents of the Financial Statements
for the Period 1 April 2023 to 30 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Carlisle Hair Loss Clinic Ltd

Company Information
for the Period 1 April 2023 to 30 March 2024







DIRECTOR: Mr Ricky Gogna





REGISTERED OFFICE: 18 Fisher Street
Fisher Street Galleries
Carlisle
England
CA3 8RH





REGISTERED NUMBER: 13250165 (England and Wales)






Carlisle Hair Loss Clinic Ltd (Registered number: 13250165)

Balance Sheet
30 March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 6,465 8,621

CURRENT ASSETS
Cash at bank 16,282 16,641

CREDITORS
Amounts falling due within one year 6 (23,578 ) (25,051 )
NET CURRENT LIABILITIES (7,296 ) (8,410 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(831

)

211

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings (931 ) 111
SHAREHOLDERS' FUNDS (831 ) 211

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 March 2025 and were signed by:




Mr Ricky Gogna - Director


Carlisle Hair Loss Clinic Ltd (Registered number: 13250165)

Notes to the Financial Statements
for the Period 1 April 2023 to 30 March 2024

1. GENERAL INFORMATION

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
18 Fisher Street
Fisher Street Galleries
Carlisle
England
CA3 8RH

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

3. ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

BASIS OF PREPARATION
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

REVENUE RECOGNITION
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

TAX
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

TANGIBLE ASSETS
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Carlisle Hair Loss Clinic Ltd (Registered number: 13250165)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 30 March 2024

3. ACCOUNTING POLICIES - continued

DEPRECIATION
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class Depreciation method and rate
Plant and Machinery 25% Written Down Value
Fixtures & Fittings 25% Written Down Value

SHARE CAPITAL
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

DIVIDEND
The director realised that the dividend declared is in excess of the reserves and hope to rectify the position in the coming year.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2023 - 1 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
At 1 April 2023
and 30 March 2024 14,000 985 14,985
DEPRECIATION
At 1 April 2023 6,125 239 6,364
Charge for period 1,969 187 2,156
At 30 March 2024 8,094 426 8,520
NET BOOK VALUE
At 30 March 2024 5,906 559 6,465
At 31 March 2023 7,875 746 8,621

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 17,100 17,100
Taxation and social security 1,293 2,210
Other creditors 5,185 5,741
23,578 25,051

Carlisle Hair Loss Clinic Ltd (Registered number: 13250165)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 30 March 2024

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary Share 1 100 100